Page 5 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contracts and orders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contracts And Orders Today - Breaking & Trending Today

MedAvail Announces Continued Expansion of Its Technology Agreement With a North Texas Health System

Press release content from Business Wire. The AP news staff was not involved in its creation.
MedAvail Announces Continued Expansion of Its Technology Agreement With a North Texas Health System
April 14, 2021 GMT
MISSISSAUGA, Ontario & PHOENIX (BUSINESS WIRE) Apr 14, 2021
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that a health system in North Texas has expanded its technology agreement with MedAvail, and has deployed MedAvail’s MedCenter technology at 16 emergency and urgent care sites in Texas.
Patients visiting these urgent and emergency care sites are able to consult virtually with a system pharmacist and fill their prescriptions at the point of care through the MedCenter, eliminating the need to make a separate trip to a pharmacy. Through MedAvail’s Pharmacy Technology segment, the company is able to enhance pharmacy services offered by healthcare providers and retail chains. ....

United States , Caroline Paul , Dave Rawlins , Medavail Medcenter , Medavail Holdings Inc , Gilmartin Group , Medavail Pharmacy Technology , Avail Holdings , North Texas , Pharmacy Technology , Chief Commercial Officer , Medavail Holdings , Business Wire , Corporate News , North America , Pharmaceutical Manufacturing , Health Care Industry , Medical Technology , Pharmacy Operators , Consumer Products And Services , Retail And Wholesale , Retail Industry , Consumer Services , Contracts And Orders , ஒன்றுபட்டது மாநிலங்களில் , கரோலின் பால் ,

CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to .
CytoDyn Inc.April 15, 2021 GMT
Under Compassionate Special Permit (CSP) in Philippines, CytoDyn is well positioned to generate significant revenues
VANCOUVER, Washington., April 15, 2021 (GLOBE NEWSWIRE) CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with potential multiple therapeutic indications, announced today it has executed an exclusive supply and distribution agreement with Chiral Pharma Corporation to supply up to 200,000 vials of leronlimab to critically ill COVID-19 patients in the Philippines under CSP authorizations. This agreement will accelerate the delivery of leronlimab upon an expanded authorization under CSP. ....

United States , British Columbia , Michael Mulholland , Nader Pourhassan , Samsung Biologics , Exchange Commission , Chiral Pharma Corporation , Drug Administration , Cytodyn Inc , Under Compassionate Special Permit , Chief Executive Officer , Chiral Pharma , Cytodyn Fast Track , Fast Track , Biologics License Application , Looking Statements , Products And Services , Government Regulations , Coronavirus Pandemic , Product Approvals , Product Testing , Globe Newswire , Pharmaceutical Manufacturing , Health Care Industry , Breast Cancer , Lung Disease ,

CleanSpark Purchases 22,680 Additional Bitcoin Miners and Anticipates 3.2 EH/s Capacity After Deployment

Press release content from PR Newswire. The AP news staff was not involved in its creation.
CleanSpark Purchases 22,680 Additional Bitcoin Miners and Anticipates 3.2 EH/s Capacity After Deployment
April 15, 2021 GMT
CleanSpark, Inc. Logo (PRNewsfoto/CleanSpark, Inc.)
SALT LAKE CITY, April 15, 2021 /PRNewswire/ CleanSpark, Inc. (Nasdaq: CLSK) (the “Company” or “CleanSpark”), a diversified software, services, and Bitcoin mining company, today announced that it has secured multiple contracts for mining equipment.
The Company has now secured contracts for all of the equipment necessary for CleanSpark’s mining operation to increase its Bitcoin mining capacity to meet its stated objective of a total hash rate capacity of more than 1.1 EH/s by summer of 2021. Additionally, CleanSpark has now secured a total of 22,680 S19j Pro and S19 Pro Antminers for future delivery under annual contracts. The Company contracted directly with Bitmain Technologies Ltd. for ....

United States , Zach Bradford , Prnewswire Cleanspark Inc , Cleanspark Inc , Company Or Cleanspark , Exchange Commission , Company Annual Report On Form , Bitmain Technologies Ltd , Bitmain Technologies , Chief Executive Officer , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Alternative And Sustainable Energy , Products And Services , Coronavirus Pandemic , Financial Technology , Environment And Nature , Pr Newswire , Lung Disease , Covid 19 Pandemic , Eco Friendly Practices , Software Industry , Infectious Diseases , Contracts And Orders , Computing And Information Technology ,

Joerns Healthcare Selected by Bristol Hospice as Sole Source Medical Equipment Service Partner

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Joerns Healthcare Selected by Bristol Hospice as Sole Source Medical Equipment Service Partner
April 15, 2021 GMT
Joerns Healthcare (PRNewsFoto/Joerns Healthcare)
CHARLOTTE, N.C., April 15, 2021 /PRNewswire/ Joerns Healthcare, LLC, a leading medical equipment services company to the care continuum, announced today that they have entered into a sole source agreement with Bristol Hospice, LLC. Joerns Healthcare’s hospice integrated business system was a key value-driver for the agreement. The pairing of Joerns Healthcare’s capability as an integrated service provider and manufacturer to provide standardized products and services in a timely, customer-centric manner, with Bristol, one of the fastest growing hospice agencies in the country with a reputation for exceptional patient and family services, is seen as a powerful partnership. ....

Salt Lake City , United States , Hyrum Kirton , Taylor Smith , Lindy Plummer , Prnewswire Joerns Healthcare , Bristol Hospice , Joerns Healthcare , Bristol Programs , Health Care Industry , Products And Services , Pr Newswire , Medical Technology , Hospice Care , Corporate News , Health Care Facility Operation , Medical Equipment And Supplies Manufacturing , Death And Dying , Medical Equipment , Hospital And Clinic Services , Health Care Services , New Products And Services , Contracts And Orders , Aging And Disability Services , உப்பு ஏரி நகரம் , ஒன்றுபட்டது மாநிலங்களில் ,

GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit

Press release content from Business Wire. The AP news staff was not involved in its creation.
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
April 14, 2021 GMT
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) Apr 14, 2021
ADVERTISEMENT
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has recently received clearance from the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates as a medical device. ....

Hong Kong , Ministry Of Health , United Arab Emirates , Comunidad Autonoma De Cataluna , Maria Jos , Hubert Thomassen , Aaron Qian , Genscript Biotech Corporation , European Division Of Genscript , Genscript Biotech Corporation Stock Code , Script Biotech , Stock Code , Life Science , Antibody Detection Kit , Use Authorized , European Division , Script Biotech Corporation , Mainland China , Emergency Medicine , Genscript Biotech , Business Wire , Public Health , Coronavirus Pandemic , Diagnosis And Treatment , Severe Acute Respiratory Syndrome , Health Care Industry ,